251 related articles for article (PubMed ID: 29499270)
1. Dosing ribavirin in hepatitis E-infected solid organ transplant recipients.
De Winter BCM; Hesselink DA; Kamar N
Pharmacol Res; 2018 Apr; 130():308-315. PubMed ID: 29499270
[TBL] [Abstract][Full Text] [Related]
2. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
[TBL] [Abstract][Full Text] [Related]
4. Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis.
Kamar N; Lhomme S; Abravanel F; Marion O; Peron JM; Alric L; Izopet J
Viruses; 2016 Aug; 8(8):. PubMed ID: 27537905
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment.
Aslan AT; Balaban HY
World J Gastroenterol; 2020 Oct; 26(37):5543-5560. PubMed ID: 33071523
[TBL] [Abstract][Full Text] [Related]
6. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
[TBL] [Abstract][Full Text] [Related]
7. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
[TBL] [Abstract][Full Text] [Related]
8. Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study.
Kamar N; Abravanel F; Behrendt P; Hofmann J; Pageaux GP; Barbet C; Moal V; Couzi L; Horvatits T; De Man RA; Cassuto E; Elsharkawy AM; Riezebos-Brilman A; Scemla A; Hillaire S; Donnelly MC; Radenne S; Sayegh J; Garrouste C; Dumortier J; Glowaki F; Matignon M; Coilly A; Figueres L; Mousson C; Minello A; Dharancy S; Rerolle JP; Lebray P; Etienne I; Perrin P; Choi M; Marion O; Izopet J;
Clin Infect Dis; 2020 Aug; 71(5):1204-1211. PubMed ID: 31793638
[TBL] [Abstract][Full Text] [Related]
9. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hepatitis E virus.
Dalton HR; Kamar N
Curr Opin Infect Dis; 2016 Dec; 29(6):639-644. PubMed ID: 27607911
[TBL] [Abstract][Full Text] [Related]
11. Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and Treatment.
Kamar N; Pischke S
Cold Spring Harb Perspect Med; 2019 Jul; 9(7):. PubMed ID: 29735575
[TBL] [Abstract][Full Text] [Related]
12. An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant Patients.
Kamar N; Lhomme S; Abravanel F; Cointault O; Esposito L; Cardeau-Desangles I; Del Bello A; Dörr G; Lavayssière L; Nogier MB; Guitard J; Ribes D; Goin AL; Broué P; Metsu D; Sauné K; Rostaing L; Izopet J
Transplantation; 2015 Oct; 99(10):2124-31. PubMed ID: 26214817
[TBL] [Abstract][Full Text] [Related]
13. The impact of hepatitis E in the liver transplant setting.
Behrendt P; Steinmann E; Manns MP; Wedemeyer H
J Hepatol; 2014 Dec; 61(6):1418-29. PubMed ID: 25195557
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatitis E after solid organ transplantation.
de Niet A; Zaaijer HL; ten Berge I; Weegink CJ; Reesink HW; Beuers U
Neth J Med; 2012 Aug; 70(6):261-6. PubMed ID: 22859417
[TBL] [Abstract][Full Text] [Related]
15. Chronic Hepatitis E Viral Infection After Liver Transplantation: A Regression of Fibrosis After Antiviral Therapy.
Mazzola A; Tran Minh M; Charlotte F; Hdiji A; Bernard D; Wendum D; Calmus Y; Conti F
Transplantation; 2017 Sep; 101(9):2083-2087. PubMed ID: 28376032
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis E Virus Infection in Lung Transplant Recipients: A Case Series.
Ambrocio GPL; Aguado S; Carrillo J; Laporta R; Lazaro-Carrasco M; Avellon A; Aran-Toha G; Ussetti M; Aguilar M
Transplant Proc; 2019 Mar; 51(2):376-379. PubMed ID: 30879545
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment.
Kamar N; Abravanel F; Lhomme S; Rostaing L; Izopet J
Clin Res Hepatol Gastroenterol; 2015 Feb; 39(1):20-7. PubMed ID: 25150374
[TBL] [Abstract][Full Text] [Related]
18. Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting.
Galante A; Pischke S; Polywka S; Luetgehethmann M; Suneetha PV; Gisa A; Hiller J; Dienes HP; Nashan B; Lohse AW; Sterneck M
Transpl Infect Dis; 2015 Aug; 17(4):617-22. PubMed ID: 26094550
[TBL] [Abstract][Full Text] [Related]
19. Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients.
Ollivier-Hourmand I; Lebedel L; Lecouf A; Allaire M; Nguyen TTN; Lier C; Dao T
BMC Infect Dis; 2020 Jul; 20(1):522. PubMed ID: 32677900
[TBL] [Abstract][Full Text] [Related]
20. [Hepatitis E virus infection].
Marion O; Izopet J; Kamar N
Rev Prat; 2018 Mar; 68(3):286-290. PubMed ID: 30869287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
